Histopathology and proteomics are synergistic for High-Grade Serous Ovarian Cancer platinum response prediction.
Journal
medRxiv : the preprint server for health sciences
Titre abrégé: medRxiv
Pays: United States
ID NLM: 101767986
Informations de publication
Date de publication:
03 Jun 2024
03 Jun 2024
Historique:
medline:
17
6
2024
pubmed:
17
6
2024
entrez:
17
6
2024
Statut:
epublish
Résumé
Patients with High-Grade Serous Ovarian Cancer (HGSOC) exhibit varied responses to treatment, with 20-30% showing
Identifiants
pubmed: 38883738
doi: 10.1101/2024.06.01.24308293
pmc: PMC11177907
pii:
doi:
Types de publication
Journal Article
Preprint
Langues
eng